Aspirins Discovered to Reduce Cancer Tumors

• comments
• 
• 

No definite cure for cancer has yet been found as of today. There are also some discoveries that found a way to prevent its spread. But recently, a new study have claimed that aspirins could cure the deadly disease.

The Sun reported that platelets having the role of forming new blood vessels. But, after new clot forms after a wound, new vessels would be required to redirect blood flow. Thus it was identified that the same process of action helps tumors grow.

Thus, a study published in Cancer Prevention Research led by Dr. Lenard Lichtenberger mentioned that Aspirins could block the reaction of platelets with cancer cells. The procedure is found out to be done by blocking the key enzyme called COX-1 to stop the activity of platelets and curbing its circulating numbers.

Yet, some experiments use aspirins that are acquired over the counter but some use a decreased intestinal damage an aspirin might cause by mixing it with phosphatidylcholine, a fat molecule. Thus that aspirin is called as Aspirin-PC/PL2200 which is said by the Texas researchers to “support the use of low-dose aspirin for chemoprevention.”

The study then summarizes that "These results suggest that aspirin's chemopreventive effects may be due, in part, to the drug blocking the proneoplastic [supporting new, abnormal growth, as in cancer] action of platelets.” With that said, the aspirin drug is concluded to have a similar chemo preventive actions compared to low-dose aspirin and may be more effective and safer chemopreventive agent for colorectal cancer and possibly other cancers.

Bioscience Technology then stated that the Aspirin-PC/PL2200 is now under PLx Pharma which Dr. Lichtenberger has a financial stake. The company is then stated to develop the lipid-based aspirin under the name Aspertec. Hence, the research group plans to test the effectiveness of the drug with people who has a high risk of colorectal cancer with the help of the MD Anderson Cancer Center in Houston.